OZAWADE® - Bioprojet
2123
portfolio_page-template-default,single,single-portfolio_page,postid-2123,bridge-core-2.9.3,,qode_grid_1200,footer_responsive_adv,qode-child-theme-ver-1.0.0,qode-theme-ver-27.7,qode-theme-bridge,qode_header_in_grid,wpb-js-composer js-comp-ver-6.7.0,vc_responsive
 

OZAWADE®

OZAWADE®

PITOLISANT (film-coated tablet)

Ozawade is indicated to improve wakefulness and reduce excessive daytime sleepiness (EDS) in adult patients with Obstructive Sleep Apnoea (OSA) whose sleepiness is not satisfactorily addressed by primary OSA treatment such as Continuous Positive Airway Pressure (CPAP) or in those who do not tolerate this treatment.

Dosages available:

  • 4,5mg
  • 18mg

Useful links

European Medicines Agency
ema.europa.eu

French Healthcare Authority
has-sante.fr